CTD-6.25mg Tablet

Description

Product Description

CTD 6.25mg Tablet contains Chlorthalidone, a thiazide-like diuretic prescribed for conditions in which lowering excess fluid and blood pressure is required. Ipca Laboratories Ltd. markets CTD 6.25 Tablet in India. Current pharmacy listings show the product in both 10- and 15-tablet presentations.

Chlorthalidone works mainly through the kidneys. It reduces the reabsorption of sodium and chloride, causing more salt and water to leave the body through urine. This reduces circulating fluid volume and contributes to lower blood pressure. Because it can also affect electrolytes and kidney function, treatment is generally monitored by a healthcare professional.

Uses

• Treatment of high blood pressure (hypertension).
• Reduction of excess fluid retention or oedema associated with certain medical conditions.
• May be prescribed alone or alongside other medicines for blood pressure control.
• Used when a diuretic effect is clinically required as part of the treatment plan.

Key Benefits

• Contains Chlorthalidone 6.25 mg in an oral tablet.
• Helps the kidneys remove excess sodium and water.
• Reduces fluid volume that can contribute to elevated blood pressure.
• Can be used as part of long-term hypertension management when prescribed.
• Provides a low-strength Chlorthalidone option for individualized treatment.

How to Use

• Take CTD 6.25mg exactly as prescribed by your doctor.
• Swallow the tablet with water.
• Take it at the time recommended by your doctor; diuretics are often scheduled earlier in the day to reduce inconvenience from increased urination.
• Take the medicine consistently according to your prescribed treatment plan.
• Do not increase, decrease or stop the medicine without medical advice.
• Your doctor may recommend blood-pressure checks and blood tests to monitor kidney function and electrolytes during treatment.

How It Works

Chlorthalidone acts on the kidneys by reducing the reabsorption of sodium and chloride in the distal part of the nephron. As more sodium remains in the urine, additional water is excreted with it. The resulting reduction in circulating fluid volume can lower blood pressure. With continued treatment, Chlorthalidone also contributes to reduced peripheral vascular resistance, which supports its antihypertensive effect.

Side Effects

• Increased urination.
• Dizziness or light-headedness.
• Headache.
• Nausea.
• Weakness or tiredness.
• Low blood pressure.
• Changes in blood sodium or potassium levels.
• Increased uric acid levels.
• Increased blood sugar levels may occur in some patients.
• Muscle cramps may occur when electrolyte levels become abnormal.

Contact your doctor if side effects are persistent, severe or accompanied by fainting, marked weakness, confusion or abnormal heartbeats.

Precautions & Warnings

• Chlorthalidone can cause significant fluid and electrolyte disturbances, including low sodium or potassium levels, which may become serious. Seek medical attention for severe weakness, confusion, fainting, muscle cramps, unusual thirst or abnormal heartbeats.
• Tell your doctor if you have kidney disease, liver disease or a history of significant electrolyte abnormalities.
• Inform your doctor if you have gout or elevated uric acid, as Chlorthalidone can increase uric acid levels and may trigger gout in susceptible people.
• Tell your doctor if you have diabetes, as treatment may affect blood glucose levels.
• Inform your doctor if you have very low blood pressure or are prone to dehydration.
• Excessive sweating, vomiting, diarrhoea or inadequate fluid intake can increase the risk of dehydration and electrolyte imbalance while taking a diuretic.
• Tell your doctor about all medicines you take, particularly other blood-pressure medicines, lithium, corticosteroids, NSAIDs and medicines that affect potassium or electrolyte levels.
• Long-term treatment may require periodic monitoring of blood pressure, kidney function, sodium, potassium and other electrolytes.
• Consult your doctor before using CTD 6.25 during pregnancy or breastfeeding.
• Do not stop prescribed hypertension treatment simply because your blood pressure readings improve; discuss any change with your doctor.
• Seek medical advice promptly if you experience severe dizziness, fainting, persistent vomiting, unusual muscle weakness or a racing or irregular heartbeat.

Storage Instructions

• Store below 25°C unless the product label specifies otherwise.
• Keep the tablets in the original blister until use.
• Protect from moisture, excessive heat and direct sunlight.
• Keep out of reach and sight of children.
• Do not use the tablets after the expiry date printed on the package.

FAQs

Q: What is CTD 6.25mg Tablet used for?
A: CTD 6.25mg is used mainly to manage high blood pressure and may also be prescribed to reduce excess fluid retention associated with certain conditions.

Q: What does CTD 6.25mg Tablet contain?
A: Each tablet contains Chlorthalidone 6.25 mg.

Q: Is CTD 6.25mg a prescription medicine?
A: Yes. Current Indian pharmacy listings classify CTD 6.25 Tablet as a prescription medicine.

Q: Does CTD 6.25mg increase urination?
A: Yes. Chlorthalidone is a diuretic, so it increases the amount of salt and water removed through urine. This effect is expected, particularly after taking the medicine.

Q: Can CTD 6.25mg affect potassium levels?
A: Yes. Chlorthalidone can alter potassium and other electrolyte levels. Your doctor may recommend blood tests during treatment, especially with prolonged use or when other medicines are involved.

Q: Who manufactures CTD 6.25mg Tablet?
A: CTD 6.25mg Tablet is marketed by Ipca Laboratories Ltd. Current listings show the medicine in both 10- and 15-tablet pack options.